The British Association for Sexual Health and HIV Special Interest Group for Sexual dysfunction examined the current guidelines and treatment mechanisms for premature ejaculation ( PE ). As a result, new guidelines were released to assist physicians in diagnosing the condition. Researchers may also use the guidelines in developing clinical trials to study premature ejaculation ( PE ).

Dapoxetine ( Priligy ™ ) is not yet approved for treating premature ejaculation, yet initial studies consider it safe and effective. The drug is quick acting, leaves the system rapidly, and long-term build-up is not evident. Different from other selective serotonin reuptake inhibitors, the drug works from the first dose.